The Strategist

Asian Pacific Markets Are To Grab The Lime-Light For Antibiotics Industry


04/07/2015 - 14:59



The growing need of research and understanding the importance of the antibiotics in the medicinal field are creating an expecting promise of the near future boost in the market.



Strategists.com – 07 April 2015 – According to a market analysis there seems to be ample scope for researches in the field of antibiotic resistance.
 
Usually, the practice of antibiotic medicine is seen in treating pathogenic diseases which is used in two situations. In the first case, it eradicates bacteria inside the body and in the second, it prevents their further development. From the year of 1928, as penicillin was discovered, the antibiotic has played a key role in the global healthcare and medicinal practices.
 
Moreover, in recent time, pushed by the modern innovative developments, the importance of antibiotic has been highlighted especially in the field of controlling side-effect caused by the antibodies. In fact, new strains of antibiotics are invented which allow the medical professionals to prescribe a particular strain for to combat a particular disease at the same time causing the minimum side-effects possible.
 
The “Transparency Market Research” informs that as and when the importance of antibiotic researches are understood by a larger crowd, the more it’s going to help the antibiotic market to gain the supports from the respective governments in many nations of the world.  As mentioned earlier, the boost of the antibiotic market saw a strong CAGR growth of 6.6% within the course of six years within 2005 and 2011. Moreover, the said commercial field is likely to achieve a market value of $44.68 Billion by the year of 2016.
 
Interestingly, the market of antibiotics is split into further specialised medicinal strains, namely penicillin, erythromycin, aminoglycoside antibiotics, streptomycin, chloramphenicol and tetracyclines. However, presently the aminoglycoside strain of antibodies seem to dominate the market with a maximum share of seventy nine percent whereas the rest including tetracyclines, chloramphenicol, erythromycin and streptomycin are in the process of gaining popularity as they together hold the twenty one percent of market share.
 
Furthermore, the research extrapolates to say that the antibiotic market of Asia Pacific is mostly likely to grow as it shows a promising future. Interestingly, as per the geographical maps, the global market for antibiotics has major four divisions which comprises of Asia Pacific, North America, Europe and the rest of the nations. But the market of Asia Pacific is likely to grow in the near future as the Asian countries including South Korea, China, and Japan, have increased their healthcare infrastructure.
 
Consequently, the biggest antibiotic markets of Europe and North America are likely to face a competition as they will be witnessing the growth of the Asian Pacific market. Nevertheless, there are apparently two major issues that can hamper the development of the global antibiotic market. The first being the growing expiry rate of patent products enabling the smaller markets to infiltrate into the production share; whereas the second concern is about the developments of a strain of antibiotics that cause the minimum side-effects.
 
Even though, the landscape of the global market of antibiotics is likely to undergo a potential change of in hierarchy, studies say that the “major market players are expected to retain their dominant market shares”. 



References:
http://www.transparencymarketresearch.com/article/antibiotic-market.htm#src=whatech